Intentional product use issue: FDA reporting patterns
86,792 FDA FAERS reports mention Intentional product use issue. 58,859 reports have a serious outcome flag.
Medicines named as suspect
- Infliximab: 20,279 reports
- Rituximab: 11,228 reports
- Tocilizumab: 5,410 reports
- Adalimumab: 4,641 reports
- Methotrexate: 4,462 reports
- Prednisone: 4,337 reports
- Abatacept: 3,948 reports
- Etanercept: 3,896 reports
- Leflunomide: 3,694 reports
- Acetaminophen: 3,522 reports
- Diclofenac: 3,374 reports
- Hydroxychloroquine: 3,331 reports
FAERS reports describe events reported after a medicine was taken. They do not prove that the medicine caused an event, measure how often a side effect occurs, or estimate personal risk.
Source: FDA FAERS via openFDA. FAERS data through 2026-06-30. Sources, methods, and limitations.